Enliven Therapeutics Inc (ELVN)
17.62
-0.16
(-0.93%)
USD |
NASDAQ |
Apr 30, 09:44
Enliven Therapeutics Market Cap: 728.75M for April 30, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 29, 2024 | 735.57M |
| April 26, 2024 | 710.35M |
| April 25, 2024 | 693.81M |
| April 24, 2024 | 723.17M |
| April 23, 2024 | 718.21M |
| April 22, 2024 | 728.54M |
| April 19, 2024 | 714.49M |
| April 18, 2024 | 730.61M |
| April 17, 2024 | 715.31M |
| April 16, 2024 | 772.79M |
| April 15, 2024 | 824.47M |
| April 12, 2024 | 871.61M |
| April 11, 2024 | 984.90M |
| April 10, 2024 | 819.51M |
| April 09, 2024 | 793.46M |
| April 08, 2024 | 756.66M |
| April 05, 2024 | 802.14M |
| April 04, 2024 | 769.07M |
| April 03, 2024 | 768.65M |
| April 02, 2024 | 777.33M |
| April 01, 2024 | 781.47M |
| March 28, 2024 | 727.30M |
| March 27, 2024 | 770.31M |
| March 26, 2024 | 728.13M |
| March 25, 2024 | 735.16M |
| Date | Value |
|---|---|
| March 22, 2024 | 764.10M |
| March 21, 2024 | 746.74M |
| March 20, 2024 | 794.29M |
| March 19, 2024 | 725.24M |
| March 18, 2024 | 522.63M |
| March 15, 2024 | 494.93M |
| March 14, 2024 | 477.15M |
| March 13, 2024 | 507.34M |
| March 12, 2024 | 527.18M |
| March 11, 2024 | 557.37M |
| March 08, 2024 | 614.84M |
| March 07, 2024 | 636.75M |
| March 06, 2024 | 638.82M |
| March 05, 2024 | 663.22M |
| March 04, 2024 | 689.26M |
| March 01, 2024 | 689.26M |
| February 29, 2024 | 659.43M |
| February 28, 2024 | 701.96M |
| February 27, 2024 | 730.04M |
| February 26, 2024 | 725.09M |
| February 23, 2024 | 682.56M |
| February 22, 2024 | 656.54M |
| February 21, 2024 | 667.28M |
| February 20, 2024 | 684.21M |
| February 16, 2024 | 693.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
417.48M
Minimum
Dec 12 2023
984.90M
Maximum
Apr 11 2024
694.16M
Average
711.50M
Median
Aug 23 2023
Market Cap Benchmarks
| Eyenovia Inc | 36.24M |
| Phathom Pharmaceuticals Inc | 543.69M |
| Lantern Pharma Inc | 54.78M |
| Vincerx Pharma Inc | 18.39M |
| NKGen Biotech Inc | 36.26M |
Market Cap Related Metrics
| Price to Book Value | 2.964 |
| Price | 17.62 |
| Earnings Yield | -9.86% |